In the 1990s, scientists at The Institute of Cancer Research identified the breast cancer 2 gene, BRCA2, and mutations in it that greatly increase the carrier’s risk of developing breast cancer and ...
Approximately one in 400 people, and one in 100 diagnosed with breast cancer, have a BRCA2 mutation, Couch said. People who have a BRCA2 loss-of-function pathogenic mutation have a 69% lifetime ...
Directly after the Supreme Court announced its decision, several companies began to offer cheaper tests for the BRCA1 and BRCA2 mutations. Myriad and its partners in the suit says that even though the ...
and BRCA2. Smith said future research will look at whether an inherited or acquired mutation may alter clinical outcome, motivating tailored precision care. Other Vanderbilt authors include ...
Followed categories will be added to My News. She has one of the most commonly inherited gene mutations – BRCA2 – which increases the risk of breast, ovarian and prostate cancers. Mia tested ...
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
Olaparib is available on the NHS. It is a possible treatment for HER2-negative, locally advanced or metastatic breast cancer with inherited (germline) BRCA1 or BRCA2 mutations in adults who have had: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results